Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.

被引:0
|
作者
Baer, Maria R. [1 ]
Ford, Laurie A. [1 ]
Bundy, Brian N. [1 ]
Tighe, Sheila M. [1 ]
O'Loughlin, Kieran L. [1 ]
Slack, James L. [1 ]
Wetzler, Meir [1 ]
Wallace, Paul K. [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4574
引用
收藏
页码:223B / 223B
页数:1
相关论文
共 50 条
  • [21] Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China
    Zhang, Xi
    Li, Yunlong
    Zhang, Yanqi
    Chen, Xinghua
    Zhang, Cheng
    Gao, Li
    Kong, Peiyan
    Liu, Yao
    Wen, Qin
    Zeng, Yunjing
    Wang, Qingyu
    Su, Yi
    Wang, Chunsen
    Wang, Sanbin
    Yuan, Zhong
    Gao, Lei
    LEUKEMIA RESEARCH, 2013, 37 (06) : 657 - 664
  • [22] Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine
    Raanani, P
    Shpilberg, O
    Gillis, S
    Avigdor, A
    Hardan, I
    Berkowicz, M
    Sofer, O
    Lossos, I
    Chetrit, A
    Ben-Yehuda, D
    Bell-Bassat, I
    LEUKEMIA RESEARCH, 1999, 23 (08) : 695 - 700
  • [23] THE EFFECTS OF GM-CSF AND G-CSF IN PROMOTING GROWTH OF CLONOGENIC CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA
    VELLENGA, E
    YOUNG, DC
    WAGNER, K
    WIPER, D
    OSTAPOVICZ, D
    GRIFFIN, JD
    BLOOD, 1987, 69 (06) : 1771 - 1776
  • [24] Mito-FLAG (mitoxantrone, fludarabine, Ara-C as bolus or continuous infusion, G-CSF) for relapsed or refractory acute myeloid leukemia.
    Hänel, M
    Friedrichsen, K
    Grundeis, M
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Teich, M
    Fiedler, F
    BLOOD, 1998, 92 (10) : 216B - 217B
  • [25] High-dose cytarabine, etoposide and cisplatin salvage chemotherapy for relapsed adult acute myeloid leukemia.
    Lee, JS
    Lee, KW
    Lee, WS
    Kim, J
    Yoon, SS
    Park, S
    Kim, BK
    BLOOD, 2003, 102 (11) : 230B - 230B
  • [26] Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
    M Fiegl
    M Unterhalt
    W Kern
    J Braess
    K Spiekermann
    P Staib
    A Grüneisen
    B Wörmann
    D Schöndube
    H Serve
    A Reichle
    M Hentrich
    X Schiel
    C Sauerland
    A Heinecke
    C Rieger
    D Beelen
    W E Berdel
    T Büchner
    W Hiddemann
    Leukemia, 2014, 28 : 1001 - 1007
  • [27] Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG
    Fiegl, M.
    Unterhalt, M.
    Kern, W.
    Braess, J.
    Spiekermann, K.
    Staib, P.
    Grueneisen, A.
    Woermann, B.
    Schoendube, D.
    Serve, H.
    Reichle, A.
    Hentrich, M.
    Schiel, X.
    Sauerland, C.
    Heinecke, A.
    Rieger, C.
    Beelen, D.
    Berdel, W. E.
    Buechner, T.
    Hiddemann, W.
    LEUKEMIA, 2014, 28 (05) : 1001 - 1007
  • [28] Efficacy and Safety of Azacytidine in Combination with Fludarabine and High-Dose Cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Open-Label, Phase II Study
    Al Aoun, Shaima
    Motabi, Ibraheem
    Al Ammari, Maged
    Al Ishehry, Nawal
    Marei, Mohammed
    Albtoosh, Bilal
    Tailor, Imran
    Altaf, Syed
    Zaidi, Sayid
    Alfayez, Mansour
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S284 - S284
  • [29] Randomized comparison of G-CSF+GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy
    Spitzer, G
    Adkins, D
    Mathews, M
    Velasquez, W
    Bowers, C
    Dunphy, F
    Kronmueller, N
    Niemeyer, R
    McIntyre, W
    Petruska, P
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 921 - 930
  • [30] High dose chemotherapy with G-CSF in refractory Hodgkin's disease
    Avilés, A
    García, EL
    Cuadra, I
    Díaz-Maqueo, JC
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 139 - 145